Gene Logic Says Review Confirms That Genomics Unit Is Weak, Drug Repositioning Has Legs

Sep 22, 2006

NEW YORK (GenomeWeb News) – Gene Logic today said that an internal business review confirmed that the firm's genomics business is weak and that the drug-repositioning business is poised to grow.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Johnson, Brexit, and Science

Nature News examines how science in the UK may fare as Boris Johnson, the next prime minister, pursues Brexit.

ICE Expands DNA Testing Sites

CNN reports that Immigration and Customs Enforcement in the US has expanded its DNA testing to seven sites along the southern border.

PNAS Papers Explore Neurogenesis Exosomes, More

In PNAS this week: role for exosomes in neuronal circuit development, tuberculosis pathogen enzymes, and more.

Undoing Obamacare protections could affect people's willingness to undergo genetic testing, Sarah Lawrence College's Laura Hercher and the University of Iowa College of Law's Anya Prince write at BuzzFeed News.

Menu